Q301--NGS Malignancy Testing

The Richard L. Roudebush VA Medical Center is seeking information from vendors capable of providing Hematologic Malignancy Next Generation Sequence (NGS) complex specialized testing and Immunohistochemistry (IHC) testing and analysis of patient specimens. The testing requires a high level of direct patient care with consistent testing methodology and results reporting to assist in developing treatment plans. The contractor shall provide specimen collection kits, transport kits, shipping labels, and a portal for online test ordering. The contractor shall also provide test results to the ordering facility in accordance with the testing specifications as defined in the contractor's commercial specimen collection guide. Some key requirements include: * Providing controls in place to be a certified laboratory per the regulatory agencies of the VA * Ensuring that all procedures performed are of current acceptable standard deviation with at least daily controls conducted to determine procedure accuracy * Providing written instructions for sample preparation, collection, and transportation of all specimens * Providing a shipping service for transport of samples to the testing facility * Providing test results to the ordering facility in accordance with the testing specifications as defined in the contractor's commercial specimen collection guide.